Corporate Overview

A Center of Excellence for What We Do

Everest Clinical Research ("Everest") is a full-service contract research organization (CRO) providing a broad range of expertise-based clinical research services to worldwide pharmaceutical, biotechnology, and medical device industries. We serve some of the best-known companies and work with many of the most advanced drugs, biologics, and medical devices in development today.

Everest has been an independent CRO since 2004 with a strong foundation as a statistical and data management center of excellence. Building on this foundation, Everest has successfully developed and established itself as a full-service CRO. Operating primarily in North America, with headquarters located in Toronto, Ontario, Canada, subsidiary offices in New Jersey, USA; Shanghai, China; and Taipei, Taiwan, Everest is known in the industry for its high quality deliverables, superior customer service, and flexibility in meeting clients’ needs. A dynamic organization with an entrepreneurial origin, Everest continues to experience exceptional growth and great success.

Quality is our backbone, customer-focus is our tradition, flexibility is our strength...that’s us…that’s Everest.

Our Mission and Story

Our mission is to provide outstanding quality, on-time delivery, and exceptional customer service to our clinical research partners.

Company Highlights

  • Created by a group of former colleagues of Pharmacia Corporation, has been an independent CRO since 2004 following Pfizer’s acquisition of Pharmacia.
  • Successfully operating for over 19 years as an independent CRO, building preferred vendor relationships with a list of global major pharmaceutical companies and over 90 mid-sized and small pharmaceutical, biotechnology, and medical device companies.
  • In December 2022, Everest acquired Brightech International, a New Jersey-based CRO that specializes in Biometrics services. Brightech was founded in 2004 and has been successfully operating for over 19 years as an independent CRO.
  • In November 2023, Everest acquired August Research, a European CRO that provides Clinical Operation and Pharmacovigilance services to a wide variety of pharmaceutical and biotechnology clients. August Research has its corporate headquarters located in Sofia Bulgaria, with clinical operations capabilities in North America, Eastern and Western European countries. August Research was founded in 2012 and has been successfully operating for over 11 years as an independent CRO.
  • A growing company with 650 full-time staff members and a resource pool of part-time and contract-based consultants.
  • Believes strongly in quality and customer care. Many of our current customers have either worked with Everest staff members in the past or learned about Everest through personal recommendations.
  • Promotes high quality standards, is customer-focused, has a can-do spirit, utilizes advanced technologies, strives for continuous improvement, and maintains a high level of ethical and professional standards.
  • Continues to be successful in servicing clients and being a center of excellence for the clinical research services Everest provides.
  • Helps clients achieve drug and medical device development goals with strong industry expertise and a proven track record.
  • Offers quality and timely services at a competitive rate.
  • Considers quality as the backbone, customer-focus as the tradition, and flexibility as the strength.

Latest News


Press Release – Acquisition of August Research


Press Release – Acquisition of Brightech International


Access clinical trial data visualizations through our Clinical Data Dashboard


We are ready for an accelerated growth in 2021 and years beyond!


We are on the battlefront fighting against COVID-19!

Are you ready to get started?

Tell us about your next project